Quantitative cell-based bioassays for therapeutic development targeting immune checkpoint and co-stimulatory receptors

被引：0
|
作者：
Grailer, Jamison
Stecha, Pete
Wang, Jun
Hartnett, Jim
Fan, Frank
Cong, Mei
Cheng, Zhi-jie Jey
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4878
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4878
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Engagement of co-stimulatory receptors differentially shapes the architecture of the CD8+T cell immunological synapse
    Prunier, G.
    Fusaro, M.
    Sagnat, D.
    De Peredo, Gonzalez A.
    Lesourne, R.
    Dupre, L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 126 - 126
  • [42] Cell-based reporter bioassays for development of Fc-functional and Fc-silent SIRPa/CD47 checkpoint inhibitors
    Mitchell, Jonathan
    Grailer, Jamison
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    Cheng, Zhijie Jey
    CANCER RESEARCH, 2020, 80 (16)
  • [43] Aged Mice Have Reduced Monocyte Cell-surface Expression Of Antigen-presenting And Co-stimulatory Receptors
    Strohacker, Kelley
    Breslin, Whitney L.
    McFarlin, Brian K.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2010, 42 (05): : 645 - 646
  • [44] Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis
    Sise, Meghan E.
    Wang, Qiyu
    Seethapathy, Harish
    Moreno, Daiana
    Harden, Destiny
    Smith, R. Neal
    Rosales, Ivy A.
    Colvin, Robert B.
    Chute, Sarah
    Cornell, Lynn D.
    Herrmann, Sandra M.
    Fadden, Riley
    Sullivan, Ryan J.
    Yang, Nancy J.
    Barmettler, Sara
    Wells, Sophia
    Gupta, Shruti
    Villani, Alexandra-Chloe
    Reynolds, Kerry L.
    Farmer, Jocelyn
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (01)
  • [45] Development of quantitative cell-based enzyme assays in microdroplets
    Huebner, Ansgar
    Olguin, Luis F.
    Bratton, Daniel
    Whyte, Graeme
    Huck, Wilhelm T. S.
    de Mello, Andrew J.
    Edel, Joshua B.
    Abell, Chris
    Hollfelder, Florian
    ANALYTICAL CHEMISTRY, 2008, 80 (10) : 3890 - 3896
  • [46] Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodies
    Ajina, Reham
    Zahavi, David J.
    Zhang, Yong-Wei
    Weiner, Louis M.
    SEMINARS IN CANCER BIOLOGY, 2020, 65 : 28 - 37
  • [47] In vivo model development for immune cell-based therapeutics
    McMichael, Elizabeth
    Jetley, Utsav
    Rudulier, Christopher
    Borah, Minasri
    Ganci, Nicole
    Ragothaman, Vandhana
    Balwani, Ishina
    Frain, Amanda
    Pajanirassa, Priya
    Miki, Yuko
    Jones, Jeffrey
    Luster, Troy
    Keenan, Marie
    Martinez, Terina
    Zhang, Yong
    Schultes, Birgit
    CANCER RESEARCH, 2020, 80 (16)
  • [48] Co-stimulatory tumor necrosis factor ligands as adjuvants for the development of subunit-based anticancer vaccines
    Shirwan, Haval
    Sharma, Rajesh K.
    Srivastava, Abhishek K.
    Yolcu, Esma S.
    ONCOIMMUNOLOGY, 2013, 2 (04)
  • [49] Dictating Phenotype, Function, and Fate of Human T Cells with Co-Stimulatory Antibodies Presented by Filamentous Immune Cell Mimics
    Schluck, Marjolein
    Eggermont, Loek J.
    Weiden, Jorieke
    Popelier, Carlijn
    Weiss, Lea
    Pilzecker, Bas
    Kolder, Sigrid
    Heinemans, Anne
    Mogeda, Carla Rodriguez
    Verdoes, Martijn
    Figdor, Carl G.
    Hammink, Roel
    ADVANCED THERAPEUTICS, 2022, 5 (04)
  • [50] B-cell-activating factor, a proliferation inducing ligand and co-stimulatory molecules in the pathogenesis of immune thrombocytopenia in childhood
    Gozmen, Salih
    Karapinar, Tuba Hilkay
    Tufekci, Ozlem
    Vergin, Canan
    Yuksel, Faize
    Irken, Gulersu
    Oren, Hale
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (05) : 494 - 499
12345